Report - SUMMARY OF CHANGES - ClinicalTrials.govProtocol NRG-GY002 NCI Version Date: 01/31/2017 - 1 - NRG ONCOLOGY . NRG-GY002 (ClinicalTrials.gov NCT #02257528) A Phase II Evaluation of Nivolumab,

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form